Presentation of “A RANDOMIZED DOUBLED BLINDED TRIAL OF TREATMENT WITH DIAMINO-OXIDASE (DAO) IN PATIENTS WITH MIGRAINE AND DEFICIT OF ENZYME’S ACTIVITY. ” in the XXI World Congress of Neurology in Vienna
Presentation in the XXI World Congress of Neurology (Vienna, Austria) of the study: A RANDOMIZED DOUBLED BLINDED TRIAL OF TREATMENT WITH DIAMINO-OXIDASE (DAO) IN PATIENTS WITH MIGRAINE AND DEFICIT OF ENZYME’S ACTIVITY.
